Critical Care Diagnostics Market

Global Critical Care Diagnostics Market Size, Trends & Analysis - Forecasts to 2026 By Test Type (Routine & Special Chemistry, Flow Cytometry, Hematology, Immunoproteins, Microbial and Infectious Diseases, Coagulation Testing) By End User (Operating Room, Emergency Room, Intensive Care Unit, Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 13 2024 with the latest and most recent market numbers

Critical Care Diagnostics Market Size

The Global Critical Care Diagnostics Market is projected to grow at a CAGR value of 6.2% from 2021 to 2026. The advancements happening in technology, as well as research and development, have made these tests easily available, contributing to the growth of the market.

Cheaper diagnostic devices and medication, increasing availability of skilled critical care workers, and the growing implementation of insurance policies are expected to drive the market forward during the forecast period.

The growing awareness about the prevention of critical diseases has caused many people to opt for regular check-ups and testing through these critical care diagnostics centers. Technological advancements in diagnostic techniques have allowed healthcare providers to administer tests quicker, allowing greater adoption of novel diagnostic tools for critical care diagnostics.

The emergence of covid-19 has led to an increase in the demand for critical care diagnostics. Complications arising from the virus have increased the strain on critical care providers to ensure rapid and on-time diagnosis. The market is expected to continue to grow rapidly owing to the impact of the pandemic during the forecast period.

global critical care diagnostics market

Critical Care Diagnostics Market: By Test Type

According to the test typically used in critical care diagnostic, the market is segmented into immunoproteins, routine and special chemistry, hematology, coagulation testing, microbial and infectious diseases, and flow cytometry. Among all these test types, the segment of immunoproteins test type is the most popular one and is expected to register the largest market size. The immunoproteins test provides a very quick result of the test hence helping to form an early and accurate diagnosis of any critical disease. So, most of the patients with any symptoms of critical diseases prefer these kinds of tests for better prevention and quicker recovery. The increasing awareness about regular check-ups and testings to prevent any critical chronic disease is raising the demand for immunoprotein tests for critical care diagnostic.

The microbial and infectious diseases test type is also expected to be the fastest-growing test type segment during the forecast period. Different infectious diseases happening all over the world including tuberculosis, Zika virus, Ebola, and the recent addition of covid-19, have raised the demand for this type of critical care diagnostic.

Critical Care Diagnostics Market: By End User

Based on the end-users, the market of critical care diagnostic is segmented into operating rooms, intensive care units, emergency rooms, and others. With the growing awareness about the prevention of critical diseases, people all over the world are now preferring more to visit the emergency rooms even when they have light symptoms of chronic diseases. With the increasing prevalence of critical diseases, the demand for these emergency rooms is rising rapidly. Especially with the emergence of covid-19 disease in 2020, the emergency rooms, in particular, are witnessing spiked growth, all over the world. The improvement and development of emergency rooms especially in developing countries are also contributing to the demand for the same.

asia pacific critical care diagnostics market

Critical Care Diagnostics Market: By Region

As per the geographical analysis, the critical care diagnostics market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Argentina, and Rest of Central and South America).

The North American region is expected to hold the largest share of the revenue during the forecast.

On the other hand, Asia Pacific is expected to be witnessing the highest compound annual growth rate.

Critical Care Diagnostics Market Share & Competitor Analysis

Some of the most significant players in the market of critical care diagnostic market are Abbott, Becton, Dickinson & Company, bioMérieux SA, Chembio Diagnostic Systems, Inc., F. Hoffmann-La Roche, Sysmex Corporation, Bayer AG, Bio-Rad Laboratories, Inc., Danaher, and Siemens Healthineers, among others.

Chapter 1 Methodology

1.1 Market Scope & Definitions

1.2 Estimates & Forecast Calculation

1.3 Historical Data Overview and Validation

1.4 Data Sources

1.4.1 Secondary

1.4.2 Primary

Chapter 2 Report Outlook

2.1 Critical Care Diagnostics Industry Overview, 2020-2026

2.1.1 Industry Overview

2.1.2 Test Type Overview

2.1.3 End-User Overview

2.1.4 Regional Overview

Chapter 3 Critical Care Diagnostics Market Trends

3.1 Market Segmentation

3.2 Industry Background, 2020-2026

3.3 Market Key Trends

3.3.1 Positive Trends

3.3.1.1 Technological advancement in critical care diagnostics

3.3.2 Industry Challenges

3.3.2.1 Rise in cost of diagnostic equipment and dearth of qualified professionals

3.4 Prospective Growth Scenario

3.4.1 Test Type Growth Scenario

3.4.2 End-User Growth Scenario

3.5 COVID-19 Influence over Industry Growth

3.6 Porter’s Analysis

3.7 PESTEL Analysis

3.8 Value Chain & Supply Chain Analysis

3.9 Regulatory Framework

3.9.1 North America

3.9.2 Europe

3.9.3 APAC

3.9.4 LATAM

3.9.5 MEA

3.10 End-User Overview

3.11 Market Share Analysis, 2020

3.11.1 Company Positioning Overview, 2020

Chapter 4 Critical Care Diagnostics Market, By Test Type

4.1 Test Type Outlook

4.2 Routine & Special Chemistry

4.2.1 Market Size, By Region, 2020-2026 (USD Billion)

4.3 Flow Cytometry

4.3.1 Market Size, By Region, 2020-2026 (USD Billion)

4.4 Hematology

4.4.1 Market Size, By Region, 2020-2026 (USD Billion)

4.5 Immunoproteins

4.5.1 Market Size, By Region, 2020-2026 (USD Billion)

4.6 Microbial and Infectious Diseases

4.6.1 Market Size, By Region, 2020-2026 (USD Billion)

4.7 Coagulation Testing

4.7.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 5 Critical Care Diagnostics Market, By End-User

5.1 End-User Outlook

5.2 Operating Room

5.2.1 Market Size, By Region, 2020-2026 (USD Billion)

5.3 Emergency Room

5.3.1 Market Size, By Region, 2020-2026 (USD Billion)

5.4 Intensive Care Unit

5.4.1 Market Size, By Region, 2020-2026 (USD Billion)

5.5 Others

5.5.1 Market Size, By Region, 2020-2026 (USD Billion)

Chapter 6 Critical Care Diagnostics Market, By Region

6.1 Regional outlook

6.2 North America

6.2.1 Market Size, By Country 2020-2026 (USD Billion)

6.2.2 Market Size, By Test Type, 2020-2026 (USD Billion)

6.2.3 Market Size, By End-User, 2020-2026 (USD Billion)

6.2.4 U.S.

6.2.4.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.2.4.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.2.5 Canada

6.2.5.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.2.5.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.3 Europe

6.3.1 Market Size, By Country 2020-2026 (USD Billion)

6.3.2 Market Size, By Test Type, 2020-2026 (USD Billion)

6.3.3 Market Size, By End-User, 2020-2026 (USD Billion)

6.3.4 Germany

6.3.4.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.3.4.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.3.5 UK

6.3.5.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.3.5.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.3.6 France

6.3.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.3.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.3.7 Italy

6.3.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.3.7.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.3.8 Spain

6.3.8.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.3.8.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.3.9 Russia

6.3.9.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.3.9.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.4 Asia Pacific

6.4.1 Market Size, By Country 2020-2026 (USD Billion)

6.4.2 Market Size, By Test Type, 2020-2026 (USD Billion)

6.4.3 Market Size, By End-User, 2020-2026 (USD Billion)

6.4.4 China

6.4.4.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.4.4.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.4.5 India

6.4.5.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.4.5.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.4.6 Japan

6.4.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.4.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.4.7 Australia

6.4.7.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.4.7.2 Market size, By End-User, 2020-2026 (USD Billion)

6.4.8 South Korea

6.4.8.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.4.8.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.5 Latin America

6.5.1 Market Size, By Country 2020-2026 (USD Billion)

6.5.2 Market Size, By Test Type, 2020-2026 (USD Billion)

6.5.3 Market Size, By End-User, 2020-2026 (USD Billion)

6.5.4 Brazil

6.5.4.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.5.4.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.5.5 Mexico

6.5.5.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.5.5.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.5.6 Argentina

6.5.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.5.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.6 MEA

6.6.1 Market Size, By Country 2020-2026 (USD Billion)

6.6.2 Market Size, By Test Type, 2020-2026 (USD Billion)

6.6.3 Market Size, By End-User, 2020-2026 (USD Billion)

6.6.4 Saudi Arabia

6.6.4.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.6.4.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.6.5 UAE

6.6.5.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.6.5.2 Market Size, By End-User, 2020-2026 (USD Billion)

6.6.6 South Africa

6.6.6.1 Market Size, By Test Type, 2020-2026 (USD Billion)

6.6.6.2 Market Size, By End-User, 2020-2026 (USD Billion)

Chapter 7 Company Landscape

7.1 Competitive Analysis, 2020

7.2 Abbott

7.2.1 Company Overview

7.2.2 Financial Analysis

7.2.3 Strategic Positioning

7.2.4 Info Graphic Analysis

7.3 Becton, Dickinson & Company

7.3.1 Company Overview

7.3.2 Financial Analysis

7.3.3 Strategic Positioning

7.3.4 Info Graphic Analysis

7.4 bioMérieux SA

7.4.1 Company Overview

7.4.2 Financial Analysis

7.4.3 Strategic Positioning

7.4.4 Info Graphic Analysis

7.5 Chembio Diagnostic Systems, Inc.

7.5.1 Company Overview

7.5.2 Financial Analysis

7.5.3 Strategic Positioning

7.5.4 Info Graphic Analysis

7.6 F. Hoffmann-La Roche

7.6.1 Company Overview

7.6.2 Financial Analysis

7.6.3 Strategic Positioning

7.6.4 Info Graphic Analysis

7.7 Sysmex Corporation

7.7.1 Company Overview

7.7.2 Financial Analysis

7.7.3 Strategic Positioning

7.7.4 Info Graphic Analysis

7.8 Bayer AG

7.8.1 Company Overview

7.8.2 Financial Analysis

7.8.3 Strategic Positioning

7.8.4 Info Graphic Analysis

7.9 Bio-Rad Laboratories, Inc.

7.9.1 Company Overview

7.9.2 Financial Analysis

7.9.3 Strategic Positioning

7.9.4 Info Graphic Analysis

7.10 Bio-Rad Laboratories, Inc.

7.10.1 Company Overview

7.10.2 Financial Analysis

7.10.3 Strategic Positioning

7.10.4 Info Graphic Analysis

7.11 Other Companies

7.11.1 Company Overview

7.11.2 Financial Analysis

7.11.3 Strategic Positioning

7.11.4 Info Graphic Analysis

The Global Critical Care Diagnostics Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Critical Care Diagnostics Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe. Privacy

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

What is the projected market size of the global critical care diagnostics market?

The global critical care diagnostics market is projected to grow at a CAGR value of 6.2% from 2021 to 2026.

Who are the major vendors in the critical care diagnostics market?

Which region has the highest market share in the critical care diagnostics market?

The North American region is estimated to hold the largest share of the critical care diagnostics market.

What is the Covid-19 impact on the future of the critical care diagnostics market?

What are the major drivers in the critical care diagnostics market?

The rapid growth for early diagnostic techniques and the broadening scope of therapeutic trials, the rapidly rising geriatric population and the resulting increase in the prevalence of chronic disorders, technological innovations in the medical diagnostic industry, and boosting investments, financing, and subsidies by public-private organizations are all driving the critical care diagnostics market forward during the forecast period.